Matrix-degrading proteases and angiogenesis during development and tumor formation
- PMID: 10190275
- DOI: 10.1111/j.1699-0463.1999.tb01521.x
Matrix-degrading proteases and angiogenesis during development and tumor formation
Abstract
Embryonic development and tumor progression both require the exquisite coordination of programs for extracellular matrix (ECM) formation and remodeling, and those for angiogenesis and vascular development. Without a vascular supply the normal tissue or tumor is limited in size and organization. Without ECM remodeling the alteration of tissue and tumor boundaries and cellular migrations are limited. Recent insights into the molecular mechanisms regulating the extracellular environment of the growing embryonic tissue or tumors have implicated proteases, the matrix metalloproteinases (MMPs) in particular, in both the process of ECM remodeling and angiogenesis, and in a potential causal relationship between these processes. This review focuses on the roles that MMPs play in regulating three processes in which both proteolysis and vascular development are tightly coordinated: embryo implantation, bone development and tumor progression.
Similar articles
-
Complex role of matrix metalloproteinases in angiogenesis.Cell Res. 1998 Sep;8(3):171-7. doi: 10.1038/cr.1998.17. Cell Res. 1998. PMID: 9791730 Review.
-
Expression and function of matrix metalloproteinases in development.Matrix Suppl. 1992;1:337-43. Matrix Suppl. 1992. PMID: 1480058
-
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28636874 Review.
-
Matrix metalloproteinases in vascular physiology and disease.Vascular. 2012 Aug;20(4):210-6. doi: 10.1258/vasc.2011.201202. Epub 2012 Aug 15. Vascular. 2012. PMID: 22896663 Review.
-
Extracellular matrix remodeling during morphogenesis.Ann N Y Acad Sci. 1998 Oct 23;857:110-8. doi: 10.1111/j.1749-6632.1998.tb10111.x. Ann N Y Acad Sci. 1998. PMID: 9917836 Review.
Cited by
-
Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling.Differentiation. 2013 Oct;86(3):92-103. doi: 10.1016/j.diff.2013.06.004. Epub 2013 Jul 12. Differentiation. 2013. PMID: 23850217 Free PMC article. Review.
-
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.Mol Cancer. 2005 Sep 9;4:33. doi: 10.1186/1476-4598-4-33. Mol Cancer. 2005. PMID: 16153302 Free PMC article.
-
Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy.J Cell Biol. 2005 Jun 20;169(6):977-85. doi: 10.1083/jcb.200411153. J Cell Biol. 2005. PMID: 15967816 Free PMC article.
-
Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2-null fibroblasts and mice.Am J Pathol. 2005 Jul;167(1):81-8. doi: 10.1016/S0002-9440(10)62955-0. Am J Pathol. 2005. PMID: 15972954 Free PMC article.
-
Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3.Invest Ophthalmol Vis Sci. 2011 Aug 3;52(9):6117-23. doi: 10.1167/iovs.10-5899. Invest Ophthalmol Vis Sci. 2011. PMID: 21282576 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources